Laurens Wachsmuth

Laurens Wachsmuth

Auto-generated profile, based on publicly available information

Laurens Wachsmuth

University of Cologne

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2022 in Nature
Verified
Journal Article
Open access
PDF file
HJHuipeng Jiao
Huipeng Jiao
LWLaurens Wachsmuth
Laurens Wachsmuth
SWSimone Wolf
Simone Wolf
JLJuliane Lohmann
Juliane Lohmann
MNMasahiro Nagata
Masahiro Nagata
MPManolis Pasparakis
Manolis Pasparakis
Mutations of theADAR1gene encoding an RNA deaminase cause severe diseases associated with chronic activation of type I interferon (IFN) responses, including Aicardi–Goutières syndrome and bilateral striatal necrosis1–3. The IFN-inducible p150 isoform of ADAR1 contains a Zα domain that recognizes RNA with an alternative left-handed double-helix structure, termed Z-RNA4,5. HemizygousADAR1mutations in the Zα domain cause type I IFN-mediated pathologies in humans2,3and mice6–8; however, it remains unclear how the interaction of ADAR1 with Z-RNA prevents IFN activation. Here we show that Z-DNA-binding protein 1 (ZBP1), the only other protein in mammals known to harbour Zα domains9, promotes type I IFN activation and fatal pathology in mice with impaired ADAR1 function. ZBP1 deficiency or mutation of its Zα domains reduced the expression of IFN-stimulated genes and largely prevented early postnatal lethality in mice with hemizygous expression of ADAR1 with mutated Zα domain (Adar1mZα/–mice).Adar1mZα/–mice showed upregulation and impaired editing of endogenous retroelement-derived complementary RNA reads, which represent a likely source of Z-RNAs activating ZBP1. Notably, ZBP1 promoted IFN activation and severe pathology inAdar1mZα/–mice in a manner independent of RIPK1, RIPK3, MLKL-mediated necroptosis and caspase-8-dependent apoptosis, suggesting a novel mechanism of action. Thus, ADAR1 prevents endogenous Z-RNA-dependent activation of pathogenic type I IFN responses by ZBP1, suggesting that ZBP1 could contribute to type I interferonopathies caused byADAR1mutations.

16 September 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
AHAnnika Hausmann
Annika Hausmann
BFBoas Felmy
Boas Felmy
LKLeo Kunz
Leo Kunz
SKSanne Kroon
Sanne Kroon
DBDorothée Lisa Berthold
Dorothée Lisa Berthold
WHWolf-Dietrich Hardt
Wolf-Dietrich Hardt
Intestinal epithelial cell (IEC) NF-κB signaling regulates the balance between mucosal homeostasis and inflammation. It is not fully understood which signals tune this balance and how bacterial exposure elicits the process. Pure LPS induces epithelial NF-κB activation in vivo. However, we found that in mice, IECs do not respond directly to LPS. Instead, tissue-resident lamina propria intercrypt macrophages sense LPS via TLR4 and rapidly secrete TNF to elicit epithelial NF-κB signaling in their immediate neighborhood. This response pattern is relevant also during oral enteropathogen infection. The macrophage–TNF–IEC axis avoids responses to luminal microbiota LPS but enables crypt- or tissue-scale epithelial NF-κB responses in proportion to the microbial threat. Thereby, intercrypt macrophages fulfill important sentinel functions as first responders to Gram-negative microbes breaching the epithelial barrier. The tunability of this crypt response allows the induction of defense mechanisms at an appropriate scale according to the localization and intensity of microbial triggers.

19 September 2024 in The EMBO Journal
Verified
Journal Article
Open access
MNMasahiro Nagata
Masahiro Nagata
YSYasmin Carvalho Schäfer
Yasmin Carvalho Schäfer
LWLaurens Wachsmuth
Laurens Wachsmuth
MPManolis Pasparakis
Manolis Pasparakis
Z-DNA-binding protein 1 (ZBP1) is an interferon-inducible sensor of Z-DNA and Z-RNA, which has emerged as a critical regulator of cell death and inflammation. ZBP1 binds Z-DNA and Z-RNA via its Zα domains, and signals by engaging RIPK3 and RIPK1 via its RIP homotypic interaction motifs (RHIMs). Here, we show that mice express an alternatively-spliced shorter ZBP1 isoform (ZBP1-S), which harbours the Zα domains but lacks the RHIMs, and acts as an endogenous inhibitor of the full-length protein (ZBP1-L). Mice and cells expressing only ZBP1-S are resistant to ZBP1-mediated cell death and inflammation. In contrast, cells lacking ZBP1-S show increased ZBP1-L-induced death compared to cells expressing both isoforms. Moreover, loss of the short isoform accelerates and exacerbates skin inflammation induced by ZBP1-mediated necroptosis of RIPK1-deficient keratinocytes, revealing an important physiological role of ZBP1-S. Mechanistically, ZBP1-S suppresses ZBP1-L-mediated cell death by binding to Z-nucleic acids via its Zα domains. Therefore, ZBP1-S acts as an endogenous inhibitor that competes with full-length ZBP1-L for binding Z-nucleic acid ligands to fine-tune ZBP1-mediated cell death and inflammation.

29 January 2026 in Science
Verified
Journal Article
Closed access
ITInes Tomaskovic
Ines Tomaskovic
CPCristian Prieto-Garcia
Cristian Prieto-Garcia
MBMaria Bošković
Maria Bošković
MGMateo Glumac
Mateo Glumac
TTTsung-Lin Tsai
Tsung-Lin Tsai
IDIvan Dikic
Ivan Dikic
DNA-protein cross-links (DPCs) are highly toxic DNA lesions that block replication and transcription, but their impact on organismal physiology is unclear. We identified a role for the metalloprotease SPRTN in preventing DPC-driven immunity and its pathological consequences. Loss of SPRTN activity during replication and mitosis lead to unresolved DNA damage, chromosome segregation errors, micronuclei formation, and cytosolic DNA release that activates the cyclic GMP-AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway. In a Sprtn knock-in mouse model of Ruijs-Aalfs progeria syndrome, chronic cGas-Sting signaling caused embryonic lethality through inflammation and innate immune responses. Surviving mice displayed aging phenotypes beginning in embryogenesis, which persisted into adulthood. Genetic or pharmacological inhibition of cGas-Sting rescued embryonic lethality and alleviated progeroid phenotypes.

23 March 2023 in Research Square
Verified
Preprint
Open access
PDF file
LKLioba Körner
Lioba Körner
LWLaurens Wachsmuth
Laurens Wachsmuth
SKSnehlata Kumari
Snehlata Kumari
RSRobin Schwarzwer
Robin Schwarzwer
HJHuipeng Jiao
Huipeng Jiao
MPManolis Pasparakis
Manolis Pasparakis
Z-DNA binding protein 1 (ZBP1) has important functions in anti-viral immunity and in the regulation of inflammatory responses. ZBP1 induces necroptosis by directly engaging and activating RIPK3, however, the mechanisms by which ZBP1 induces inflammation and in particular the role of RIPK1 and the contribution of cell death-independent signaling remain elusive. Here we show that ZBP1 causes inflammation by inducing RIPK3-mediated necroptosis and RIPK1-caspase-8-mediated apoptosis. ZBP1 induced TNFR1-independent skin inflammation in mice with epidermis-specific ablation of FADD by triggering keratinocyte necroptosis. Moreover, transgenic expression of C-terminally truncated constitutively active ZBP1 (ZBP1ca) in mouse epidermis caused skin inflammation that was only partially inhibited by abrogation of RIPK3-MLKL-dependent necroptosis and fully prevented by combined deficiency in MLKL and caspase-8. Importantly, ZBP1ca induced caspase-8-mediated skin inflammation by RHIM-dependent but kinase activity-independent RIPK1 signaling. Furthermore, ZBP1ca-induced inflammatory cytokine production in the skin was completely prevented by combined inhibition of apoptosis and necroptosis arguing against a cell death-independent pro-inflammatory function of ZBP1. Collectively, these results showed that ZBP1 induces inflammation by activating necroptosis and RIPK1 kinase activity-independent apoptosis.

13 April 2026 in Research Square
Verified
Preprint
Open access
MPManolis Pasparakis
Manolis Pasparakis
NSNeil Stair
Neil Stair
JSJohanna Seiler
Johanna Seiler
JMJonathan Mannion
Jonathan Mannion
NVNathalia de Vasconcelos
Nathalia de Vasconcelos
LWLaurens Wachsmuth
Laurens Wachsmuth
Caspase-8 is a central regulator of death receptor signalling. It induces apoptosis and suppresses necroptosis through its catalytic activity, while it serves as a scaffold promoting inflammasome activation and NF-κB-mediated gene expression. The currently prevailing model is that homo-oligomerization promotes full activation of caspase-8 to induce apoptosis, while heterodimerization with its catalytically inactive homologue cFLIP mediates limited activation of caspase-8 to suppress necroptosis. Here, we show that caspase-8 homo-oligomerisation not only initiates apoptosis but also plays a critical role in inhibiting necroptosis in susceptible cell types in vivo and in vitro. Inhibition of caspase-8 homo-oligomerisation by knock-in mutation of critical residues in its second DED (F122G/L123G; Casp8 FGLG/FGLG ) prevented hepatocyte apoptosis and the development of hepatitis and hepatocellular carcinoma in mice lacking NEMO specifically in liver parenchymal cells. In this model, inhibition of caspase-8 homo-oligomerisation did not sensitize hepatocytes to necroptosis because these cells do not express RIPK3. In contrast, in the Sharpin cpdm/cpdm mouse model of dermatitis induced by caspase-8-dependent keratinocyte apoptosis, Casp8 FGLG/FGLG /FGLG mutation suppressed apoptosis but did not prevent skin inflammation. Combined inhibition of caspase-8 homo-oligomerisation and necroptosis fully prevented dermatitis in Sharpin cpdm/cpdm mice, demonstrating that inhibition of caspase-8 homo-oligomerization sensitized keratinocytes to MLKL-dependent necroptosis. Consistently, primary cells from Casp8 FGLG/FGLG mice were protected from apoptosis but became highly sensitized to necroptosis in response to TNF and FasL stimulation. Mechanistically, caspase-8(FGLG) expression altered TNFR1 complex II and Fas DISC assembly to promote RIPK3 recruitment and activation. Taken together, our results challenge the prevailing model of necroptosis inhibition by caspase-8 and suggest that distinct mechanisms of caspase-8 activation cooperate to regulate apoptotic and necroptotic signalling and tissue homeostasis.